schizophrenia, bipolar disorder, autism spectrum disorder, attention deficit hyperactivity disorder
Conditions
Interventions
None listed
Sponsors
Chiba University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients: 1) Subjects are diagnosed with schizophrenia, bipolar disorder, autism spectrum disorder, or attention deficit hyperactivity disorder using DSM-5 diagnostic criteria. 2) Subjects are treated in the department of psychiatry in Chiba University Hospital (and other hospitals that participate in this research project). 3) Subjects have participated in the research project HS202405-02 Clinical Genetic Research on Neuropsychiatric Disorders (Principal Investigator: Tomihisa Niitsu. 4) Subjects are aged between 18 and 65 years old at the time of obtaining consent. 5) Subjects have been fully informed of the study and have given their written consent freely and voluntarily after sufficient understanding. 6) Subjects are Japanese. Healthy: 1) Subjects are not diagnosed with mental illness. 2) Subjects have participated in the research project HS202405-02 Clinical Genetic Research on Neuropsychiatric Disorders (Principal Investigator: Tomihisa Niitsu. 3) Subjects are aged between 18 and 65 years old at the time of obtaining consent. 4) Subjects have been fully informed of the study and have given their written consent freely and voluntarily after sufficient understanding. 5) Subjects are Japanese.
Exclusion criteria
Exclusion criteria: The following people are not eligible for the study 1) Subjects with a history of head injury, epilepsy, or loss of consciousness (for more than 3 minutes) 2) Subjects with a serious physical illness 3) Subjects who have not been informed of their diagnosis at the time of obtaining consent 4) Subjects with comorbid clinical target diseases (schizophrenia, bipolar disorder, autism spectrum disorder, attention deficit hyperactivity disorder) and whose clinical picture cannot be said to be dominated by any one of the psychiatric disorders. 5) Subjects with imminent suicidal ideation or suicidal behaviour. 6) Subjects who are pregnant, may be pregnant, within 28 days of giving birth, or breastfeeding. 7) Any other person who is deemed by the attending physician or the principal investigator or sub-investigator to be unsuitable for the safe conduct of the study. For healthy people, apply the items excluding 3) above.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood protein concentration, disease severity, previous adverse experiences. | — |
Countries
Japan
Contacts
Public ContactNobuhisa Kanahara
Chiba University Center for Forensic Mental Health Division of Clinical Neuroscience
Outcome results
None listed